Chatham Capital Group Inc. increased its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 0.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,476 shares of the company’s stock after purchasing an additional 135 […]